Read article—Features Corneliu Stanciu, an assistant professor of psychiatry, discussing the health risks and treatment challenges associated with kratom and its synthetic derivative, 7-OH, which are marketed as herbal supplements but function like opioids. “The problem is that there’s no standard when it comes to testing,” Stanciu said.

Read article—Nicholas Cochran-Caggiano, a professor of emergency medicine, co-authors an article examining how new federal Medicaid work requirements could threaten patients’ access to care and the financial stability of emergency departments nationwide. “The experiences of Arkansas and Georgia serve as cautionary tales, highlighting that bureaucratic barriers, not lack of effort, often drive disenrollment,” the co-authors wrote.

Read article—Features research from Dartmouth and Dartmouth-Hitchcock examining vaccine hesitancy before and after the COVID-19 pandemic, finding stable uptake of TDAP vaccines but declines in HPV vaccination. “We are now seeing that there’s an absolute meteoric rise in oral cancers, especially HPV-associated,” says Ilana Cass, Guarini ’24, professor of obstetrics and gynecology.

Read article—Features a study by Marcus Shaker, a professor of pediatrics and medicine, that finds routine screening for alpha-gal syndrome—a life-threatening allergy to red meat and other mammal products—in asymptomatic patients is generally not cost-effective. “The central issue is that the test may be sensitive but not always very specific, and a nonspecific test can generate worry and harm without adding benefit,” Shaker said.

Read article—Outlines research by Ilana Cass, professor of obstetrics and gynecology, and PhD candidate Elizabeth Anderson that shows an association between declining human papillomavirus vaccination (HPV) rates and the release of the COVID-19 vaccine.

Read article—Daniel R Lucey, MD a clinical professor of medicine at Geisel School of Medicine was quoted in an article on a paper published recently on Chikungunya virus infection in late pregnancy and potential harm by the virus on babies.

Read article—Features the results of a clinical trial led by Shelby Sullivan, professor of medicine, reporting that a routine outpatient procedure can prevent weight rebound for patients coming off of GLP-1 drugs.

Read article—Features Shelby Sullivan, a professor of medicine, discussing initial results of a clinical trial she’s leading that showing a routine outpatient procedure can prevent weight rebound for patients transitioning off of GLP-1 drugs. “If validated in the full trial, this procedure could fundamentally change how we think about GLP-1 therapy,” Sullivan said. (Similar coverage in Welltica, HealthDay, and DocWire News.)

Read article—Karen Fortuna, assistant professor of community and family medicine, and Vedan Taplivana ’26, created an app for tracking Alzheimer’s progression. The app, called RealVision, tracks how users interact with their phones, noting such changes as disoriented eye movement, difficulty with typing, or needing more time to respond to prompts. “Some of these patterns are quite nuanced and may not be easily noticeable to the human eye in real time,” Fortuna said. “That’s where computational approaches can help by detecting patterns across many small signals over time.”